Pfizer Ltd share price logo

Pfizer Ltd (PFIZER)

₹5301.152.11%

bell
Get free price alerts. Set up your Free investment account to get Live Prices.
Overview
News
Financials
Q1 2024 Results
Technicals

Analyst Rating

based on 3 analysts

BUY

66.67%

Buy

33.33%

Hold

0.00%

Sell

Based on 3 analysts offering long term price targets for Pfizer Ltd. An average target of ₹4975

Source: S&P Global Market Intelligence

Pfizer Ltd Share analysis

Source: S&P Global Market Intelligence

Performance

  • Day's Low

    Day's High

    ₹5,142.05
    ₹5,344
  • 52 Week's Low

    52 Week's High

    ₹3,800.1
    ₹5,344
1 Month Return+ 12.67 %
3 Month Return+ 25.13 %
1 Year Return+ 34.63 %
Previous Close₹5,191.40
Open₹5,200.00
Volume37.54K
Upper Circuit-
Lower Circuit-
Market Cap₹23,749.48Cr

Key Statistics

P/E Ratio0
PEG Ratio0
Market Cap₹23,749.48 Cr
P/B Ratio4.94
EPS14.13

Mutual Fund Holdings

Funds HoldingsPrev. 6M
Nippon India Small Cap Fund - Direct Plan - Growth PlanNippon India Small Cap Fund - Direct Plan - Growth Plan0.82%
Nippon India Multi Cap Fund - Direct Plan - GrowthNippon India Multi Cap Fund - Direct Plan - Growth0.47%
Nippon India Pharma Fund - Direct Plan - Growth PlanNippon India Pharma Fund - Direct Plan - Growth Plan1.95%
ICICI Prudential Smallcap Fund Direct Plan GrowthICICI Prudential Smallcap Fund Direct Plan Growth1.22%
UTI Mid Cap Fund-Growth Option- DirectUTI Mid Cap Fund-Growth Option- Direct0.84%

Company Information

Pfizer Limited is a leading pharmaceutical company that has been active in India since 1950, and has built up a strong portfolio with 43 manufacturing sites in 125 countries. They have 6 primary therapeutic areas including Oncology, Hospital Vaccines, Inflammation and Immunology, and have managed to keep up with cutting-edge technology with research and clinical trials. Over the years Pfizer Limited has seen many changes, from a Merger with ParkeDavis in 2002 and the closure of a manufacturing plant at Ankleshwar in 1999 to being the first company to introduce hormone replacement therapy and conjugated pneumococcal vaccines in India. In 2015 the plant located at Thane Belapur Road Navi Mumbai was transferred to a going concern with the sale to Vidhi Research and Development LLP, and in 2017 Pfizer acquired the brand Neksium with active ingredient Esomeprazole. The Goa plant was recognized with the India Manufacturing Excellence Award-Future Ready Factory of the Year Award 2017 and the Pfizer's President's Platinum Award for 2017. Pfizer Inc. USA, the Ultimate Holding Company, completed the transaction of combining its Upjohn Business with Mylan N.V. in 2019. Currently the company earns a revenue of Rs 176 Crore (nine months period ended in 2019) for their Corex brand, with Rs 244 Crore in profit for the financial year ending in 2016. Pfizer Limited continues to innovate and grow in the Indian market.

Share Price: ₹5301.15 per share as on 24 Jul, 2024 04:01 PM
Market Capitalisation: ₹23,749.48Cr as of today
Listing date: 09 Dec, 1994
Chairperson Name: Pradip P Shah
OrganisationPfizer Ltd
Headquarters
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Key events for Pfizer Ltd

  • Multinational Pharma Companies Downsizing in India - 27 Jun, 2024

    Most multinational pharma companies, including Pfizer, are downsizing in India due to intense competition from domestic companies and lower realizations. These companies have a non-differentiated branded generics portfolio with limited incremental investment, resulting in MNCs losing market share over the years.

  • Pfizer Receives Penalty Order from State Tax Department - 24 Jun, 2024

    Pharmaceutical company Pfizer Ltd has received a penalty order of Rs 14.19 lakh from the Deputy Commissioner of State Tax in Dehradun for the financial year 2017-18. The company believes the demand is unjustified and is preparing to appeal against the order.

  • Pfizer Ltd Receives Penalty Order from State Tax Department - 23 Jun, 2024

    Pfizer Ltd has received a penalty order of Rs 14.19 lakh for the financial year 2017-18 under the Value Added Tax Act, 2005. The company is preparing an appeal against the order as they believe that the demand is not maintainable.

  • Pfizer Ltd's Stock Increases by 6.1% in Three Months - 22 Jun, 2024

    Pfizer Ltd's stock has increased by 6.1% over the past three months, with attention being paid to its ROE of 15%. The company's financial indicators are being analyzed to determine their role in recent price movements.

Insights on Pfizer Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 7.61% to 7.73% in Mar 2024 quarter

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 3.03% to 3.32% in Mar 2024 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, PFIZER stock has moved up by 2.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Zydus Lifesciences Ltd has given 87.2% return, outperforming this stock by 52.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 127.7% return, outperforming this stock by 136.2%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 63.92% of holdings in Mar 2024 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 17.90% to 17.42% in Mar 2024 quarter

Company Financials

Value in ₹ crore
2023Y/Y Change
Total Assets
₹4,001.35Cr
↑2.20%
Total Liabilities
₹794.05Cr
↓24.43%
Value in ₹ crore
2023Y/Y Change
Operating Cash Flow
₹355.68Cr
↓46.68%

Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
63.92%
0.00
Foreign Institutions
3.32%
0.00
Mutual Funds
7.72%
0.00
Retail Investors
17.42%
0.00
Others
7.61%
0.00

Key Indicators

Earnings and Dividends

  • Pfizer Ltd Earnings Results

    Pfizer Ltd’s net profit jumped 37.96% since last year same period to ₹178.86Cr in the Q4 2023-2024. On a quarterly growth basis, Pfizer Ltd has generated 37.61% jump in its net profits since last 3-months.

    Read More about Earnings Results
  • Pfizer Ltd Dividends May,2023

    In the quarter ending March 2023, Pfizer Ltd has declared dividend of ₹35 - translating a dividend yield of 2.02%.

    Read More about Dividends

Technicals Summary

Bearish

Neutral

Bullish

Bullish

Pfizer Ltd is currently in a Bullish trading position according to technical analysis indicators.

Frequently Asked Questions

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Pfizer Ltd shares.

Pfizer Ltd (PFIZER) share price today is ₹5301.15

Pfizer Ltd is listed on NSE

Pfizer Ltd is listed on BSE

  • Today’s highest price of Pfizer Ltd is ₹5344.
  • Today’s lowest price of Pfizer Ltd is ₹5142.05.

Today’s traded volume of Pfizer Ltd(PFIZER) is 37.54K.

Today’s market capitalisation of Pfizer Ltd(PFIZER) is ₹23749.48Cr.

Pfizer Ltd(PFIZERPrice
52 Week High
₹5344
52 Week Low
₹3800.1

Pfizer Ltd(PFIZER) share price is ₹5301.15. It is down -0.80% from its 52 Week High price of ₹5344

Pfizer Ltd(PFIZER) share price is ₹5301.15. It is up 39.50% from its 52 Week Low price of ₹3800.1

Pfizer Ltd(PFIZERReturns
1 Day Returns
109.75%
1 Month Returns
12.67%
3 Month Returns
25.13%
1 Year Returns
34.63%